Physician profile
Raymond J Abdo
NPI 1629076674
$251,436.80
in general payments reported to CMS, 2019-2025
37 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $36K · 2021: $39K · 2022: $35K · 2023: $40K · 2024: $18K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Food and Beverage: $16K · Travel and Lodging: $8,208 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Long Term Medical Supply Or Device Loan: $765 · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,674.34 |
| Food and Beverage | $16,113.37 |
| Travel and Lodging | $8,207.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Long Term Medical Supply Or Device Loan | $765.33 |
| Education | $678.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $71,177.42 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Reprise Biomedical, INC. | $64,614.82 | 2019-2025 | Miro3d, Miro3d Fibers, Mirodry |
| Organogenesis INC. | $61,627.38 | 2019-2023 | Nushield, Puraply |
| Convatec INC. | $17,122.78 | 2021-2025 | |
| Ets Wound Care LLC | $10,791.14 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Imbed Biosciences INC. | $5,170.46 | 2023 | |
| Flower Orthopedics Coporation | $3,478.56 | 2019 | |
| Royal Biologics, INC. | $3,413.62 | 2024 | |
| Kerecis Limited | $2,351.42 | 2020-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Arthrex, INC. | $2,330.74 | 2021-2023 | |
| Elite Orthopedics, LLC | $2,201.56 | 2020-2024 | |
| Miromatrix Medical INC. | $1,743.00 | 2019 | |
| Next Science LLC | $1,068.03 | 2023-2025 | Xperience, Blastx, Surgx |
| Progenacare Global, LLC | $853.01 | 2023-2024 | |
| Triad Life Sciences INC. | $768.04 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $584.51 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Abbvie INC. | $467.01 | 2021-2022 | |
| Nuo Therapeutics | $296.18 | 2023 | |
| Acera Surgical, INC. | $203.32 | 2021-2022 | |
| Allergan, INC. | $195.84 | 2019-2020 | |
| Stryker Corporation | $163.65 | 2023-2025 | Viaflow, Easyfuse, Pro-Dense |
| Cook Medical LLC | $152.20 | 2024-2025 | Zilver Ptx |
| Tactile Systems Technology INC | $131.56 | 2019 | |
| Hartmann USA, INC. | $106.68 | 2025 | Zetuvit Plus 10x10 P10 |
| Lifenet Health | $81.17 | 2025 | Theragenesis Wound Matrix |
| Globus Medical, INC. | $74.35 | 2025 | Senza |
| Avita Medical Americas, LLC | $55.52 | 2024 | |
| Epsfl, LLC | $53.84 | 2023 | |
| Biocomposites INC | $20.60 | 2019 | |
| Sanara Medtech INC. | $20.28 | 2023 | Celleraterx |
| Solventum Corporation | $19.70 | 2024 | 3m Cavilon, Activ.A.C., Promogran Prisma |
| Paratek Pharmaceuticals, INC. | $18.95 | 2025 | Nuzyra |
| Treace Medical Concepts, INC. | $18.79 | 2023 | |
| Misonix INC | $16.87 | 2019 | |
| Zyla Life Sciences, INC. | $16.24 | 2019 | |
| Kci USA, INC. | $14.21 | 2021 | |
| Arteriocyte Medical Systems, INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Abdo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.